Champions Oncology Inc
NASDAQ:CSBR

Watchlist Manager
Champions Oncology Inc Logo
Champions Oncology Inc
NASDAQ:CSBR
Watchlist
Price: 6.16 USD -1.75% Market Closed
Market Cap: 84.9m USD

Champions Oncology Inc
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Champions Oncology Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Champions Oncology Inc
NASDAQ:CSBR
Income from Continuing Operations
$2.9m
CAGR 3-Years
92%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Income from Continuing Operations
$6.6B
CAGR 3-Years
-3%
CAGR 5-Years
6%
CAGR 10-Years
13%
Danaher Corp
NYSE:DHR
Income from Continuing Operations
$3.5B
CAGR 3-Years
-16%
CAGR 5-Years
2%
CAGR 10-Years
6%
Mettler-Toledo International Inc
NYSE:MTD
Income from Continuing Operations
$835.7m
CAGR 3-Years
0%
CAGR 5-Years
8%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Income from Continuing Operations
$1.3B
CAGR 3-Years
1%
CAGR 5-Years
13%
CAGR 10-Years
12%
IQVIA Holdings Inc
NYSE:IQV
Income from Continuing Operations
$1.3B
CAGR 3-Years
3%
CAGR 5-Years
46%
CAGR 10-Years
13%
No Stocks Found

Champions Oncology Inc
Glance View

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Baltimore, Maryland and currently employs 194 full-time employees. This technology includes the Company’s in-vivo, ex-vivo and biomarker platforms, oncology software solutions, and computational-based discovery platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology. The Company’s software as a service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. The Company’s drug discovery and development business leverages the computational and experimental capabilities within its platforms. Their discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify novel therapeutic targets.

CSBR Intrinsic Value
HIDDEN
Show

See Also

What is Champions Oncology Inc's Income from Continuing Operations?
Income from Continuing Operations
2.9m USD

Based on the financial report for Jul 31, 2025, Champions Oncology Inc's Income from Continuing Operations amounts to 2.9m USD.

What is Champions Oncology Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
92%

The average annual Income from Continuing Operations growth rates for Champions Oncology Inc have been 92% over the past three years .

Back to Top